Sponsor:
CardioFocus
Code:
NCT03168659
Conditions
Atrial Fibrillation
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
HeartLight
Ablation
Brief summary:
Conditions
Atrial Fibrillation
Study ID
NCT03168659
Start date
Jun 16, 2017
Status verified date
Aug, 2024
Completion date
Oct, 2028
Anticipated
Primary completion date
Oct, 2026
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
250 participants
Anticipated
Intervention Model
Single group
Primary purpose
Treatment
Arms
other: Treatment
Interventions
HeartLight
Ablation
Primary outcome measure
Central contacts
Locations
University of Arizona Sarver HeartCenter
Recruiting
Tucson, Arizona, United States, 85724
Principal Investigator:
Mathew Hutchinson, MD
University of Illinois
Recruiting
Chicago, Illinois, United States, 60612
Principal Investigator:
Erik Wissner, MD
Mount Sinai Hospital
Recruiting
New York, New York, United States, 10029
Contacts
Betsy Ellsworth, MSN, ANP
betsy.ellsworth@mountsinai.orgPrincipal Investigator:
Srini Dukkipati, MD
University Of Virginia Health System
Recruiting
Charlottesville, Virginia, United States, 22908
Contacts
Principal Investigator:
J. Michael Mangrum, MD
Sponsor
CardioFocus
Last update posted
Aug 20, 2024
Last verified
Aug, 2024
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by CardioFocus on 2024-08-20.